Cullinan Therapeutics, Inc.
CGEM
$8.71
$0.202.35%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -14.58% | 23.94% | 34.71% | 10.83% | -0.05% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -29.66% | 35.78% | 137.75% | 52.56% | 82.79% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -13.65% | 24.19% | 36.04% | 11.70% | 1.21% |
|
|
|||||
| Total Current Assets | -13.65% | 24.19% | 36.04% | 11.70% | 1.21% |
| Net Property, Plant & Equipment | -33.47% | -30.37% | -36.53% | -35.77% | -33.41% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -20.26% | 0.22% | 0.22% | 0.22% | 0.00% |
| Total Assets | 28.43% | 32.05% | 30.51% | -12.73% | -13.71% |
|
|
|||||
| Total Accounts Payable | -32.53% | 122.40% | -37.63% | 82.52% | -6.28% |
| Total Accrued Expenses | 12.61% | 9.61% | 46.53% | 34.59% | 94.05% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -9.58% | -18.68% | -26.45% | -14.48% | 1.34% |
| Total Finance Division Other Current Liabilities | 57.22% | 8.30% | 115.53% | -83.70% | -85.35% |
| Total Other Current Liabilities | 57.22% | 8.30% | 115.53% | -83.70% | -85.35% |
| Total Current Liabilities | 8.92% | 3.24% | 19.31% | -16.22% | 25.06% |
|
|
|||||
| Total Current Liabilities | 8.92% | 3.24% | 19.31% | -16.22% | 25.06% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -60.51% | -51.43% | -44.44% | -41.96% | -40.11% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 3.99% | -1.92% | 11.54% | -19.00% | 16.10% |
|
|
|||||
| Common Stock & APIC | 46.44% | 46.46% | 46.58% | 12.06% | 11.85% |
| Retained Earnings | -83.33% | -81.07% | -103.11% | -125.26% | -321.13% |
| Treasury Stock & Other | -3.10% | 192.29% | 70.71% | 73.35% | 95.04% |
| Total Common Equity | 30.11% | 33.92% | 31.36% | -12.35% | -15.20% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 30.11% | 33.92% | 31.36% | -12.35% | -15.20% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 30.06% | 33.92% | 31.36% | -12.35% | -15.16% |
|
|
|||||
